Literature DB >> 14732755

Effects of off-pump versus on-pump coronary surgery on reversible and irreversible myocardial injury: a randomized trial using cardiovascular magnetic resonance imaging and biochemical markers.

Joseph B Selvanayagam1, Steffen E Petersen, Jane M Francis, Matthew D Robson, Attila Kardos, Stefan Neubauer, David P Taggart.   

Abstract

BACKGROUND: There is biochemical evidence that off-pump coronary artery bypass grafting (OPCABG) reduces myocardial injury compared with the use of cardiopulmonary bypass (ONCABG), but the functional significance of this is uncertain. We hypothesized that OPCABG surgery would result in reduced postoperative reversible (stunning) and irreversible myocardial injury, as assessed by cardiovascular MRI (CMRI). METHODS AND
RESULTS: In a single-center randomized trial, 60 patients undergoing multivessel total arterial revascularization were randomly assigned: 30 to OPCABG and 30 to ONCABG. Patients underwent preoperative and early postoperative cine MRI for assessment of global left ventricular function, and contrast-enhanced CMRI for assessment of irreversible myocardial injury. Serial troponin I measurements were obtained perioperatively and correlated with the CMRI findings. The mean preoperative cardiac index was similar in the 2 surgical groups (2.9+/-0.7 ONCABG; 2.9+/-0.8 OPCABG; P=0.9). After surgery, the cardiac index was significantly higher in the OPCABG group (2.7+/-0.6 ONCABG; 3.2+/-0.8 OPCABG; P=0.04). New irreversible myocardial injury was similar in incidence (36% ONCABG; 44% OPCABG; P=0.8) and magnitude (6.3+/-3.6 g ONCABG; 6.8+/-4.0 g OPCABG; P=0.9) across the 2 groups. The median area-under-the-curve (AUC) troponin I values were significantly larger in the ONCABG group (182 versus 135 microg/L; P=0.02). There was a moderate correlation between the troponin I AUC values and mean mass of new myocardial hyperenhancement (r(2)=0.4; P=0.008).
CONCLUSIONS: OPCABG results in significantly better left ventricular function early after surgery but does not reduce the incidence or extent of irreversible myocardial injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14732755     DOI: 10.1161/01.CIR.0000109489.71945.BD

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

Review 1.  Cardiovascular magnetic resonance and the evaluation of heart failure.

Authors:  James C C Moon; Sanjay K Prasad
Journal:  Curr Cardiol Rep       Date:  2005-01       Impact factor: 2.931

2.  Correlation of coronary artery bypass surgery-related myonecrosis with grafted vessel calibre: insights from cardiovascular magnetic resonance imaging.

Authors:  J B Selvanayagam; N Searle; S Neubauer; D P Taggart
Journal:  Heart       Date:  2006-09       Impact factor: 5.994

Review 3.  Pump or no pump for coronary artery bypass: current best available evidence.

Authors:  Shahzad G Raja
Journal:  Tex Heart Inst J       Date:  2005

Review 4.  A systematic review of the quality of publications reporting coronary artery bypass grafting trials.

Authors:  Forough Farrokhyar; Rong Chu; Richard Whitlock; Lehana Thabane
Journal:  Can J Surg       Date:  2007-08       Impact factor: 2.089

Review 5.  Cardioprotection during cardiac surgery.

Authors:  Derek J Hausenloy; Edney Boston-Griffiths; Derek M Yellon
Journal:  Cardiovasc Res       Date:  2012-03-22       Impact factor: 10.787

Review 6.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White
Journal:  Nat Rev Cardiol       Date:  2012-08-25       Impact factor: 32.419

7.  Postoperative Functional Outcome After Off-Pump Versus On-Pump Coronary Artery Bypass Grafting Using Gated Myocardial SPECT: A Comparison by Propensity Score Analysis.

Authors:  Jong Jin Lee; Won Jun Kang; Jin Chul Paeng; Dong Soo Lee; Ki-Bong Kim; June-Key Chung; Myung Chul Lee
Journal:  Nucl Med Mol Imaging       Date:  2010-04-22

8.  Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease.

Authors:  H Bülow; C Klein; I Kuehn; R Hollweck; S G Nekolla; K Schreiber; F Haas; J Böhm; B Schnackenburg; R Lange; M Schwaiger
Journal:  Heart       Date:  2005-09       Impact factor: 5.994

9.  Current trends in coronary revascularization.

Authors:  Shannon M Dunlay; Charanjit S Rihal; Thoralf M Sundt; Yariv Gerber; Véronique L Roger
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-02

10.  Mechanisms of Post-Infarct Left Ventricular Remodeling.

Authors:  Brent A French; Christopher M Kramer
Journal:  Drug Discov Today Dis Mech       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.